![](/img/cover-not-exists.png)
762 Results of a phase I/II study in metastatic renal cell carcinoma patients treated with an adjuvant HLA personalized peptide vaccine after resection of metastases and comparison to a contemporary cohort of patients with mRCC
Bedke, J., Rausch, S., Gouttefangeas, C., Kruck, S., Walter, K., Feyerabend, S., Hennenlotter, J., Laske, K., Stevanovic, S., Rammensee, H-G., Stenzl, A.Volume:
15
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/s1569-9056(16)60764-9
Date:
March, 2016
File:
PDF, 109 KB
english, 2016